Cargando…
Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease
BACKGROUND: Research from our laboratory, and that of other investigators, has demonstrated augmented levels of diacylglycerols (DAG) in the frontal cortex and plasma of subjects with Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). We have extended these observations to investigate the...
Autores principales: | Wood, Paul L., Tippireddy, Soumya, Feriante, Joshua, Woltjer, Randall L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841652/ https://www.ncbi.nlm.nih.gov/pubmed/29513680 http://dx.doi.org/10.1371/journal.pone.0191815 |
Ejemplares similares
-
Plasma lipidomics of tuberculosis patients: altered phosphatidylcholine remodeling
por: Wood, Paul L, et al.
Publicado: (2017) -
Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson’s Disease and Lewy Body Disease
por: Beger, Aaron W., et al.
Publicado: (2022) -
Serine ether glycerophospholipids: Decrements in the frontal cortex associated with mild cognitive impairment and Alzheimer’s disease
por: Wood, Paul L., et al.
Publicado: (2022) -
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
por: Garcia-Esparcia, Paula, et al.
Publicado: (2017) -
LRRK2 in Parkinson's disease and dementia with Lewy bodies
por: Zhu, Xiongwei, et al.
Publicado: (2006)